Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
22m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
22m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
46m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
46m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
46m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Larimar Therapeutics Inc logo

Larimar Therapeutics Inc

About

Larimar Therapeutics Inc (NASDAQ:LRMR) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 19 2026
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4 2026
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Feb 25 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Feb 25 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Feb 24 2026
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026

Financials

Revenue
$0
Market Cap
$497.6 M
EPS
-2.27

Community Chat

Ask AI

6ix6ixAIEvents